Clinical Trial: Effects of Infusion Timing on Treatment Response in Solid Tumors

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07630168) titled 'Effects of Infusion Timing on Treatment Response in Solid Tumors' on June 01.

Brief Summary: This study evaluates whether the time of day when immunotherapy is given affects clinical outcomes. It includes patients eligible for PD-1 (programmed cell death protein 1) or PD-L1 (programmed death-ligand 1) inhibitor treatment who have either advanced or metastatic non-small cell lung cancer (NSCLC) or locally advanced, resectable head and neck squamous cell carcinoma (HNSCC).The study tests the hypothesis that outcomes differ based on infusion timing (morning versus afternoon). Patients are divided into two cohorts by disease type: Cohort...